South Korea · Delayed Price · Currency is KRW Kyongbo Pharmaceutical Statistics
Total Valuation
KRX:214390 has a market cap or net worth of KRW 163.04 billion. The enterprise value is 281.67 billion.
| Market Cap | 163.04B |
| Enterprise Value | 281.67B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
KRX:214390 has 23.91 million shares outstanding. The number of shares has decreased by -4.71% in one year.
| Current Share Class | 23.91M |
| Shares Outstanding | 23.91M |
| Shares Change (YoY) | -4.71% |
| Shares Change (QoQ) | -18.74% |
| Owned by Insiders (%) | 17.15% |
| Owned by Institutions (%) | 0.09% |
| Float | 9.13M |
Valuation Ratios
The trailing PE ratio is 894.40.
| PE Ratio | 894.40 |
| Forward PE | n/a |
| PS Ratio | 0.62 |
| PB Ratio | 1.12 |
| P/TBV Ratio | 1.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 21.87 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.49, with an EV/FCF ratio of -8.26.
| EV / Earnings | 1,545.12 |
| EV / Sales | 1.07 |
| EV / EBITDA | 13.49 |
| EV / EBIT | 36.73 |
| EV / FCF | -8.26 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.87.
| Current Ratio | 1.08 |
| Quick Ratio | 0.49 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 7.57 |
| Debt / FCF | -3.72 |
| Interest Coverage | 0.82 |
Financial Efficiency
Return on equity (ROE) is 0.12% and return on invested capital (ROIC) is 0.54%.
| Return on Equity (ROE) | 0.12% |
| Return on Assets (ROA) | 0.73% |
| Return on Invested Capital (ROIC) | 0.54% |
| Return on Capital Employed (ROCE) | 2.04% |
| Weighted Average Cost of Capital (WACC) | 4.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.88 |
| Inventory Turnover | 1.89 |
Taxes
In the past 12 months, KRX:214390 has paid 267.20 million in taxes.
| Income Tax | 267.20M |
| Effective Tax Rate | 59.44% |
Stock Price Statistics
The stock price has increased by +22.52% in the last 52 weeks. The beta is 0.51, so KRX:214390's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +22.52% |
| 50-Day Moving Average | 6,631.80 |
| 200-Day Moving Average | 5,882.45 |
| Relative Strength Index (RSI) | 47.34 |
| Average Volume (20 Days) | 571,031 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:214390 had revenue of KRW 264.10 billion and earned 182.29 million in profits. Earnings per share was 8.00.
| Revenue | 264.10B |
| Gross Profit | 102.30B |
| Operating Income | 3.52B |
| Pretax Income | 449.49M |
| Net Income | 182.29M |
| EBITDA | 16.72B |
| EBIT | 3.52B |
| Earnings Per Share (EPS) | 8.00 |
Balance Sheet
The company has 8.05 billion in cash and 126.67 billion in debt, with a net cash position of -118.62 billion or -4,961.88 per share.
| Cash & Cash Equivalents | 8.05B |
| Total Debt | 126.67B |
| Net Cash | -118.62B |
| Net Cash Per Share | -4,961.88 |
| Equity (Book Value) | 145.74B |
| Book Value Per Share | 7,501.92 |
| Working Capital | 11.89B |
Cash Flow
In the last 12 months, operating cash flow was 7.46 billion and capital expenditures -41.54 billion, giving a free cash flow of -34.08 billion.
| Operating Cash Flow | 7.46B |
| Capital Expenditures | -41.54B |
| Depreciation & Amortization | 13.20B |
| Net Borrowing | 34.96B |
| Free Cash Flow | -34.08B |
| FCF Per Share | -1,425.64 |
Margins
Gross margin is 38.74%, with operating and profit margins of 1.33% and 0.07%.
| Gross Margin | 38.74% |
| Operating Margin | 1.33% |
| Pretax Margin | 0.17% |
| Profit Margin | 0.07% |
| EBITDA Margin | 6.33% |
| EBIT Margin | 1.33% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.73%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 0.73% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 655.72% |
| Buyback Yield | 4.71% |
| Shareholder Yield | 5.45% |
| Earnings Yield | 0.11% |
| FCF Yield | -20.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KRX:214390 has an Altman Z-Score of 1.81 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.81 |
| Piotroski F-Score | 6 |